vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与SOUTHSIDE BANCSHARES INC（SBSI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是SOUTHSIDE BANCSHARES INC的1.2倍（$75.5M vs $62.8M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -4.8%），SOUTHSIDE BANCSHARES INC自由现金流更多（$73.5M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -0.2%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Southside Bancshares Inc.是总部位于美国得克萨斯州的银行控股公司，提供个人及商业银行服务，涵盖存款账户、住房抵押贷款、消费及商业贷款、财富管理等业务，服务对象包括零售客户、中小企业及本地社区群体。
PBYI vs SBSI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$62.8M
营收增速更快
PBYI
高出32.5%
-4.8%
自由现金流更多
SBSI
多$59.1M
$14.4M
两年增速更快
PBYI
近两年复合增速
-0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $62.8M |
| 净利润 | — | $21.0M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 39.4% |
| 净利率 | — | 33.4% |
| 营收同比 | 27.7% | -4.8% |
| 净利润同比 | — | -3.7% |
| 每股收益（稀释后） | $0.26 | $0.70 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISBSI
| Q4 25 | $75.5M | $62.8M | ||
| Q3 25 | $54.5M | $43.7M | ||
| Q2 25 | $52.4M | $66.4M | ||
| Q1 25 | $46.0M | $64.1M | ||
| Q4 24 | $59.1M | $66.0M | ||
| Q3 24 | $80.5M | $63.6M | ||
| Q2 24 | $47.1M | $65.2M | ||
| Q1 24 | $43.8M | $63.1M |
净利润PBYISBSI
| Q4 25 | — | $21.0M | ||
| Q3 25 | $8.8M | $4.9M | ||
| Q2 25 | $5.9M | $21.8M | ||
| Q1 25 | $3.0M | $21.5M | ||
| Q4 24 | — | $21.8M | ||
| Q3 24 | $20.3M | $20.5M | ||
| Q2 24 | $-4.5M | $24.7M | ||
| Q1 24 | $-4.8M | $21.5M |
毛利率PBYISBSI
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYISBSI
| Q4 25 | 22.7% | 39.4% | ||
| Q3 25 | 17.6% | 11.7% | ||
| Q2 25 | 12.7% | 40.0% | ||
| Q1 25 | 8.7% | 40.9% | ||
| Q4 24 | 22.6% | 40.1% | ||
| Q3 24 | 27.4% | 39.2% | ||
| Q2 24 | -4.6% | 45.9% | ||
| Q1 24 | -5.3% | 41.4% |
净利率PBYISBSI
| Q4 25 | — | 33.4% | ||
| Q3 25 | 16.2% | 11.2% | ||
| Q2 25 | 11.2% | 32.8% | ||
| Q1 25 | 6.5% | 33.6% | ||
| Q4 24 | — | 33.0% | ||
| Q3 24 | 25.2% | 32.3% | ||
| Q2 24 | -9.6% | 37.9% | ||
| Q1 24 | -11.0% | 34.1% |
每股收益（稀释后）PBYISBSI
| Q4 25 | $0.26 | $0.70 | ||
| Q3 25 | $0.17 | $0.16 | ||
| Q2 25 | $0.12 | $0.72 | ||
| Q1 25 | $0.06 | $0.71 | ||
| Q4 24 | $0.40 | $0.71 | ||
| Q3 24 | $0.41 | $0.68 | ||
| Q2 24 | $-0.09 | $0.81 | ||
| Q1 24 | $-0.10 | $0.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $389.8M |
| 总债务越低越好 | $22.7M | $300.0M |
| 股东权益账面价值 | $130.3M | $847.6M |
| 总资产 | $216.3M | $8.5B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资PBYISBSI
| Q4 25 | $97.5M | $389.8M | ||
| Q3 25 | $94.4M | $466.9M | ||
| Q2 25 | $96.0M | $390.1M | ||
| Q1 25 | $93.2M | $431.0M | ||
| Q4 24 | $101.0M | $426.2M | ||
| Q3 24 | $96.7M | $486.3M | ||
| Q2 24 | $96.8M | $452.0M | ||
| Q1 24 | $107.2M | $469.4M |
总债务PBYISBSI
| Q4 25 | $22.7M | $300.0M | ||
| Q3 25 | $34.0M | $299.9M | ||
| Q2 25 | $45.3M | $152.4M | ||
| Q1 25 | $56.7M | $152.4M | ||
| Q4 24 | $68.0M | $152.3M | ||
| Q3 24 | $79.3M | $152.3M | ||
| Q2 24 | $90.7M | $152.2M | ||
| Q1 24 | $102.0M | $154.2M |
股东权益PBYISBSI
| Q4 25 | $130.3M | $847.6M | ||
| Q3 25 | $115.3M | $834.9M | ||
| Q2 25 | $104.7M | $807.2M | ||
| Q1 25 | $97.1M | $816.6M | ||
| Q4 24 | $92.1M | $811.9M | ||
| Q3 24 | $71.1M | $805.3M | ||
| Q2 24 | $48.5M | $801.0M | ||
| Q1 24 | $51.0M | $787.9M |
总资产PBYISBSI
| Q4 25 | $216.3M | $8.5B | ||
| Q3 25 | $202.9M | $8.4B | ||
| Q2 25 | $194.9M | $8.3B | ||
| Q1 25 | $196.2M | $8.3B | ||
| Q4 24 | $213.3M | $8.5B | ||
| Q3 24 | $220.7M | $8.4B | ||
| Q2 24 | $205.0M | $8.4B | ||
| Q1 24 | $214.1M | $8.4B |
负债/权益比PBYISBSI
| Q4 25 | 0.17× | 0.35× | ||
| Q3 25 | 0.30× | 0.36× | ||
| Q2 25 | 0.43× | 0.19× | ||
| Q1 25 | 0.58× | 0.19× | ||
| Q4 24 | 0.74× | 0.19× | ||
| Q3 24 | 1.12× | 0.19× | ||
| Q2 24 | 1.87× | 0.19× | ||
| Q1 24 | 2.00× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $93.8M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $73.5M |
| 自由现金流率自由现金流/营收 | 19.1% | 117.0% |
| 资本支出强度资本支出/营收 | 0.0% | 32.4% |
| 现金转化率经营现金流/净利润 | — | 4.47× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $130.4M |
8季度趋势，按日历期对齐
经营现金流PBYISBSI
| Q4 25 | $14.4M | $93.8M | ||
| Q3 25 | $9.7M | $40.2M | ||
| Q2 25 | $14.1M | $5.9M | ||
| Q1 25 | $3.6M | $23.9M | ||
| Q4 24 | $15.6M | $101.8M | ||
| Q3 24 | $11.0M | $-11.7M | ||
| Q2 24 | $1.0M | $16.5M | ||
| Q1 24 | $11.2M | $58.3M |
自由现金流PBYISBSI
| Q4 25 | $14.4M | $73.5M | ||
| Q3 25 | $9.7M | $37.4M | ||
| Q2 25 | $14.1M | $-2.0M | ||
| Q1 25 | $3.6M | $21.5M | ||
| Q4 24 | $15.6M | $90.7M | ||
| Q3 24 | $11.0M | $-14.2M | ||
| Q2 24 | $1.0M | $15.4M | ||
| Q1 24 | — | $55.7M |
自由现金流率PBYISBSI
| Q4 25 | 19.1% | 117.0% | ||
| Q3 25 | 17.7% | 85.5% | ||
| Q2 25 | 26.8% | -3.0% | ||
| Q1 25 | 7.7% | 33.6% | ||
| Q4 24 | 26.4% | 137.4% | ||
| Q3 24 | 13.7% | -22.3% | ||
| Q2 24 | 2.1% | 23.6% | ||
| Q1 24 | — | 88.4% |
资本支出强度PBYISBSI
| Q4 25 | 0.0% | 32.4% | ||
| Q3 25 | 0.0% | 6.5% | ||
| Q2 25 | 0.0% | 12.0% | ||
| Q1 25 | 0.1% | 3.8% | ||
| Q4 24 | 0.0% | 16.9% | ||
| Q3 24 | 0.0% | 3.8% | ||
| Q2 24 | 0.0% | 1.7% | ||
| Q1 24 | 0.0% | 4.1% |
现金转化率PBYISBSI
| Q4 25 | — | 4.47× | ||
| Q3 25 | 1.10× | 8.18× | ||
| Q2 25 | 2.41× | 0.27× | ||
| Q1 25 | 1.21× | 1.11× | ||
| Q4 24 | — | 4.67× | ||
| Q3 24 | 0.54× | -0.57× | ||
| Q2 24 | — | 0.67× | ||
| Q1 24 | — | 2.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
